Therapeutic Potential of Sodium Selenite in Letrozole Induced Polycystic Ovary Syndrome Rat Model: Targeting Mitochondrial Approach (Selenium In PCOS)
(2022). Therapeutic Potential of Sodium Selenite in Letrozole Induced Polycystic Ovary Syndrome Rat Model: Targeting Mitochondrial Approach (Selenium In PCOS). EKB Journal Management System, 2(1), -. doi: 10.21608/esdlj.2022.455727
. "Therapeutic Potential of Sodium Selenite in Letrozole Induced Polycystic Ovary Syndrome Rat Model: Targeting Mitochondrial Approach (Selenium In PCOS)". EKB Journal Management System, 2, 1, 2022, -. doi: 10.21608/esdlj.2022.455727
(2022). 'Therapeutic Potential of Sodium Selenite in Letrozole Induced Polycystic Ovary Syndrome Rat Model: Targeting Mitochondrial Approach (Selenium In PCOS)', EKB Journal Management System, 2(1), pp. -. doi: 10.21608/esdlj.2022.455727
Therapeutic Potential of Sodium Selenite in Letrozole Induced Polycystic Ovary Syndrome Rat Model: Targeting Mitochondrial Approach (Selenium In PCOS). EKB Journal Management System, 2022; 2(1): -. doi: 10.21608/esdlj.2022.455727

Therapeutic Potential of Sodium Selenite in Letrozole Induced Polycystic Ovary Syndrome Rat Model: Targeting Mitochondrial Approach (Selenium In PCOS)

Egyptian Society of Diabetes and Lipidology Journal
Volume 2, Issue 1, April 2022    PDF (67.61 K)
Document Type: Abstracts
DOI: 10.21608/esdlj.2022.455727
Abstract
Polycystic ovary syndrome (PCOS) is the most common endorinopathy in fertile women with heterogeneous reproductive and metabolic phenotypes and unknown etiology. 
Statistics
Article View: 22
PDF Download: 7